{"title":"Design, verification and validation of a spatially confined magnetic nanoparticle thermal therapy device for conformal thermal dose contouring.","authors":"Yash Sharad Lad, Shreeniket Pawar, Trent Townsend, Naveen Kondreddy, Anilchandra Attaluri","doi":"10.1080/02656736.2026.2717301","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Magnetic nanoparticle thermal therapy (MNTT) can localize heat within tumors, but non-uniform nanoparticle distribution can limit thermal dose coverage. Spatially confined MNTT (SC-MNTT) addresses this limitation by using a static magnetic field (SMF) to suppress heating outside a selected field-free region (FFR). However, SC-MNTT platforms require improved FFR steering and closed-loop temperature control.</p><p><strong>Purpose: </strong>This study developed and validated a low-cost, four-permanent-magnet SC-MNTT platform for spatially selective heating, dynamic FFR steering, and controlled thermal dose delivery in phantom models.</p><p><strong>Methods: </strong>The device combined four permanent magnets, an induction coil, motion and heating control, fiber-optic thermometry, and autotuning proportional-integral-derivative (PID) control. SMF maps and alternating magnetic field (AMF) defined operating conditions. Three-vial verification experiments evaluated spatially selective heating under pulsed AMF exposure. Liver-phantom validation experiments tested pulsed heating and autotuning PID control using prescribed temperature setpoint, a CEM43 target of 8 [min], and a healthy-tissue limit of 39.50 [°C].</p><p><strong>Results: </strong>The four-magnet configuration shifted the FFR between selected targets and concentrated heating at the intended nanoparticle location. In three-vial experiments, the selected vial reached normalized heating intensity near 1.00, while non-target vials remained lower between 0.09-0.26, corresponding to selective heating with reduced off-target activation. In liver-phantom experiments, autotuning PID control maintained a mean target temperatures 43.44 ± 0.01 [°C], achieved prescribed CEM43 at selected tumor probes, and kept the designated healthy-tissue probe below the safety threshold. Mean overshoot remained below 1.1 [%].</p><p><strong>Conclusion: </strong>The four-magnet SC-MNTT platform enabled repeatable in-plane FFR steering, spatially confined heating, and closed-loop thermal dose delivery in phantom models.</p>","PeriodicalId":520653,"journal":{"name":"International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group","volume":"43 1","pages":"2717301"},"PeriodicalIF":3.0000,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13639875/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/02656736.2026.2717301","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/19 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Magnetic nanoparticle thermal therapy (MNTT) can localize heat within tumors, but non-uniform nanoparticle distribution can limit thermal dose coverage. Spatially confined MNTT (SC-MNTT) addresses this limitation by using a static magnetic field (SMF) to suppress heating outside a selected field-free region (FFR). However, SC-MNTT platforms require improved FFR steering and closed-loop temperature control.
Purpose: This study developed and validated a low-cost, four-permanent-magnet SC-MNTT platform for spatially selective heating, dynamic FFR steering, and controlled thermal dose delivery in phantom models.
Methods: The device combined four permanent magnets, an induction coil, motion and heating control, fiber-optic thermometry, and autotuning proportional-integral-derivative (PID) control. SMF maps and alternating magnetic field (AMF) defined operating conditions. Three-vial verification experiments evaluated spatially selective heating under pulsed AMF exposure. Liver-phantom validation experiments tested pulsed heating and autotuning PID control using prescribed temperature setpoint, a CEM43 target of 8 [min], and a healthy-tissue limit of 39.50 [°C].
Results: The four-magnet configuration shifted the FFR between selected targets and concentrated heating at the intended nanoparticle location. In three-vial experiments, the selected vial reached normalized heating intensity near 1.00, while non-target vials remained lower between 0.09-0.26, corresponding to selective heating with reduced off-target activation. In liver-phantom experiments, autotuning PID control maintained a mean target temperatures 43.44 ± 0.01 [°C], achieved prescribed CEM43 at selected tumor probes, and kept the designated healthy-tissue probe below the safety threshold. Mean overshoot remained below 1.1 [%].
Conclusion: The four-magnet SC-MNTT platform enabled repeatable in-plane FFR steering, spatially confined heating, and closed-loop thermal dose delivery in phantom models.